Related Experiment Video
Updated: Jun 27, 2025
Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
Published on: August 26, 2009
Multifunctional DNA Nanoflower Applied for High Specific Photodynamic Cancer Therapy In Vivo
Hao Zheng1, Xue-Nan Feng2, Xiang-Wan-Er Jin1
1College of Life Sciences, Nankai University, 94 Weijin Road, Nankai District, Tianjin, China.
Abstract:
Photodynamic therapy (PDT) is a newly emerged strategy for disease treatment. One challenge of the application of PDT drugs is the side-effect caused by the non-specificity of the photosensitive molecules. Most of the photosensitizers may invade not only the pathogenic cells but also the normal cells. In recent, people tried to use special cargoes to deliver the drugs into target cells. DNA nanoflowers (NFs) are a kind of newly-emerged nanomaterial which constructed through DNA rolling cycle amplification (RCA) reaction. It is reported that the DNA NFs were suitable materials which have been widely applied as nanocargos for drug delivery in cancer chemotherapeutic treatment. In this paper, we have introduced a new multifunctional DNA NF which could be prepared through an one-pot RCA reaction. This proposed DNA NF contained a versatile AS1411 G-quadruplex moiety, which plays key roles not only for specific recognition of cancer cells but also for near-infrared ray based photodynamic therapy when conjugating with a special porphyrin molecule. We demonstrated that the DNA NF showed good selectivity toward cancer cells, leading to highly efficient photo-induced cytotoxicity. Moreover, the in vivo experiment results suggested this DNA NF is a promising nanomaterial for clinical PDT.
Insights
This study introduces a novel DNA nanoflower for targeted photodynamic therapy (PDT), improving drug specificity and reducing side effects. The DNA nanoflower shows promise for effective cancer treatment with enhanced in vivo performance.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Photodynamic therapy (PDT) faces challenges due to photosensitizer non-specificity, causing side effects by affecting normal cells.
- DNA nanoflowers (NFs) are emerging nanomaterials used as drug delivery vehicles, particularly in cancer treatment.
- Targeted drug delivery systems are crucial to enhance therapeutic efficacy and minimize off-target effects in PDT.
Purpose of the Study:
- To develop a multifunctional DNA nanoflower for targeted cancer cell recognition and near-infrared (NIR) activated photodynamic therapy (PDT).
- To investigate the potential of DNA NFs as specific nanocargos for improving PDT drug delivery and efficacy.
- To evaluate the in vitro and in vivo performance of the novel DNA NF for clinical applications.
Main Methods:
- Fabrication of a multifunctional DNA nanoflower using a one-pot rolling circle amplification (RCA) reaction.
- Incorporation of an AS1411 G-quadruplex moiety for cancer cell recognition and conjugation with a porphyrin molecule for PDT.
- Assessment of DNA NF selectivity towards cancer cells and evaluation of photo-induced cytotoxicity in vitro.
- In vivo experiments to determine the therapeutic potential and efficacy of the DNA NF in a clinical context.
Main Results:
- The developed DNA nanoflower demonstrated high selectivity for cancer cells, minimizing interaction with normal cells.
- Conjugation with a porphyrin molecule enabled efficient near-infrared (NIR) activated photodynamic therapy.
- The DNA nanoflower exhibited significant photo-induced cytotoxicity against cancer cells.
- In vivo studies indicated promising therapeutic outcomes, suggesting potential for clinical PDT.
Conclusions:
- The novel multifunctional DNA nanoflower offers a promising strategy for targeted cancer therapy by enhancing PDT specificity.
- This DNA NF platform provides a versatile approach for drug delivery, improving therapeutic outcomes and reducing side effects.
- The findings support the potential of this DNA NF as a clinically relevant nanomaterial for photodynamic therapy applications.
